| 1 |
31163215 | Inhibition of human cytochrome P450 2A6 by 7-hydroxycoumarin analogues: Analysis of the structure-activity relationship and isoform selectivity. | 2019 Aug 1 |
1 |
| 2 |
24337438 | A model predicting fluindione dose requirement in elderly inpatients including genotypes, body weight, and amiodarone. | 2014 Apr 1 |
1 |
| 3 |
21469766 | Validation of a rapid and inexpensive allele-specific amplification (ASA)-PCR genotyping assay for vitamin K antagonist pharmacogenomics. | 2011 Feb 1 |
1 |
| 4 |
21651319 | Pharmacogenetics of coumarin dosing: prevalence of CYP2C9 and VKORC1 polymorphisms in the Lebanese population. | 2011 Nov |
2 |
| 5 |
19883715 | Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. | 2010 Jan |
1 |
| 6 |
20121287 | Variant VKORC1 and CYP2C9 alleles in patients with diffuse alveolar hemorrhage caused by oral anticoagulants. | 2010 Feb 1 |
2 |
| 7 |
20205664 | Pharmacogenetics of oral anticoagulant therapy. | 2010 |
3 |
| 8 |
20585445 | A novel, single algorithm approach to predict acenocoumarol dose based on CYP2C9 and VKORC1 allele variants. | 2010 Jun 18 |
1 |
| 9 |
19397481 | Pharmacogenetics of vitamin K antagonists: useful or hype? | 2009 |
1 |
| 10 |
22461099 | Pharmacogenetics of cardiovascular drug therapy. | 2009 Jan |
1 |
| 11 |
17124101 | Pharmacogenetics-based coumarin therapy. | 2006 |
2 |
| 12 |
15961979 | Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants. | 2005 Jun |
1 |
| 13 |
14760217 | Pharmacogenetics and anticoagulant therapy. | 2003 Aug-Oct |
1 |